We use a combination of an oral medication with the ultra violet light device accomplishing two important purposes; it activates certain molecules inducing apoptosis (a gentle way of destroying abnormal cells) and it activates the monocytes.   The monocytes then convert into dendritic cells, (the cells which initiate immune reactions).  In 24 hours we see the evidence of our work.  Overnight, the monocytes enter the dendritic cell pathway.